Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | September 14, 2023 | September 19, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date September 14, 2023 · Filed September 19, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,760 |
Ending reported balance
After 2023-09-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-09-14 · Sale · Disposed 3,000 · Balance 63,760 F1: Mr. Schmieder is no longer a director of the Company effective August 25, 2023 F2: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023 Row 2 · 2023-09-15 · Sale · Disposed 1,000 · Balance 62,760 F2: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Schmieder is no longer a director of the Company effective August 25, 2023
F2: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2019 Filed Feb 8, 2019 23:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 2,500 | $232.70 | $581,750.00 |
DisclosureSEC source: 0001228924-19-000003 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,939 Read SEC document |
| December 03, 2018 Filed Dec 10, 2018 18:22 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000039 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,439 Read SEC document |
| November 07, 2018 Filed Nov 28, 2018 22:39 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000034 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,169 F1 · shares: Restricted Stock Units that vest on November 7, 2019 and convert into common stock on a one-for-one basis. Read SEC document |
| November 07, 2018 Filed Jun 17, 2019 17:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 2 · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000024 · primary_doc.xml · derivative · entry 4 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: Restricted Stock Units that vest on November 7, 2019 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:29 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 450 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001228924-18-000018 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,450 Underlying: Common Stock · 450 shares Expires 2024-04-02 F2 · derivative.exercise_date: 1/5 exercisable on each of the first five anniversary dates Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:29 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000018 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,019 F1 · shares: Restricted Stock Award that vests 1/5 on June 15, 2019 and 1/5 on the next four anniversary dates thereafter Read SEC document |
| April 02, 2018 Filed Jun 17, 2019 17:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Unit -1 · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000024 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted stock units that vest 1/5 on June 15, 2019 and each of the next four June 15's thereafter F3 · derivative.expiration_date: Not Applicable Read SEC document |
| February 08, 2018 Filed Feb 8, 2018 22:36 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 3,000 | $132.27 | $396,810.00 |
DisclosureSEC source: 0001228924-18-000002 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,869 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 830 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-17-000016 · primary_doc.xml · derivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,830 Underlying: Common Stock · 830 shares Expires 2023-04-03 F1 · derivative.exercise_date: 20% exercisable on each of first 5 anniversary dates Read SEC document |
| April 03, 2017 Filed Apr 21, 2017 22:16 UTC Amendment | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-17-000024 · primary_doc.xml · derivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 1,000 shares Expires 2023-04-03 F1 · derivative.exercise_date: 20% exercisable on each of the first 5 anniversary dates Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 15:23 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommmon Stock | 2,000 | $122.90 | $245,800.00 |
DisclosureSEC source: 0001228924-17-000002 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,869 Read SEC document |
| January 13, 2013 Filed Jan 17, 2023 15:52 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherCommon Stock | 1,000 | $122.66 | $122,660.00 |
DisclosureSEC source: 0001228924-23-000001 · primary_doc.xml · nonDerivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,547 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.